NGL Fine-Chem (NSE:NGLFINE) LT-Debt-to-Total-Asset: 0.10 (As of Mar. 2026)

What is NGL Fine-Chem LT-Debt-to-Total-Asset?

NGL Fine-Chem NSE:NGLFINE +4.28% 78 LT-Debt-to-Total-Asset is 0.10 as of Mar. 2026. GuruFocus rates NSE:NGLFINE with a GF Score™ of 78/100 and a GF Value™ of ₹2,823.05 (Modestly Overvalued). The stock has 8 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. NGL Fine-Chem's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.10.

NGL Fine-Chem's long-term debt to total assets ratio increased from Mar. 2025 (0.06) to Mar. 2026 (0.10). It may suggest that NGL Fine-Chem is progressively becoming more dependent on debt to grow their business.

NGL Fine-Chem (NSE:NGLFINE) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

NGL Fine-Chem LT-Debt-to-Total-Asset Related Terms

NGL Fine-Chem LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for NGL Fine-Chem's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NGL Fine-Chem LT-Debt-to-Total-Asset Chart

NGL Fine-Chem Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.00

0.06

0.10

NGL Fine-Chem Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.06	0.00	0.07	0.00	0.10

78GF Score

NGL Fine-Chem Ltd NSE:NGLFINE

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

NGL Fine-Chem LT-Debt-to-Total-Asset Calculation

NGL Fine-Chem's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )	/	Total Assets (A: Mar. 2026 )
	=	564.033	/	5454.958
	=	0.10

NGL Fine-Chem's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	564.033	/	5454.958
	=	0.10

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.10 mean?

NGL Fine-Chem (NSE:NGLFINE) has a LT-Debt-to-Total-Asset of 0.10 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on NGL Fine-Chem and its competitors.

Is NGL Fine-Chem's LT-Debt-to-Total-Asset too high?

NGL Fine-Chem's current LT-Debt-to-Total-Asset is 0.10. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does NGL Fine-Chem's LT-Debt-to-Total-Asset compare to LLY and JNJ?

NGL Fine-Chem's LT-Debt-to-Total-Asset of 0.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on NGL Fine-Chem and its competitors. NGL Fine-Chem's current LT-Debt-to-Total-Asset is 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is NGL Fine-Chem stock overvalued right now?

Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,823.05, compared to a current price of ₹3,224.60 — trading 14.2% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.10. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current LT-Debt-to-Total-Asset is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?

Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued. The current stock price of ₹3,224.60 is trading 14.2% above its estimated GF Value™ of ₹2,823.05. GuruFocus considers NGL Fine-Chem to be Modestly Overvalued.

Key valuation signals for NSE:NGLFINE:

LT-Debt-to-Total-Asset: 0.10
GF Value™: ₹2,823.05 vs. price of ₹3,224.60 (14.2% above fair value)
GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NGL Fine-Chem Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:507747 NSE:SAIPARENT BOM:524280 NSE:ACCPL NSE:QUESTLAB BOM:532815 NSE:SENORES BOM:500674 LLY JNJ ABBV XSWX:ROP MRK XSWX:NOVN LSE:AZN OCSE:NOVO B AMGN GILD PFE BMY

Other Exchanges 524774:India

Address 301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057

Website https://www.nglfinechem.com

NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.

78GF Score

Get the complete analysis for NSE:NGLFINE

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,224.60

Price

₹2,823.05

GF Value

View NSE:NGLFINE Analysis

See LT-Debt-to-Total-Asset data for all stocks →